Oramed Pharmaceuticals, Inc. (ORMP)

3.39 +0.07 (+2.11%) USD  |  NASDAQ  |  Jan 23, 16:00
3.40 +0.01 (+0.29%) After-Hours: 20:00
More

Oramed Pharmaceuticals Free Cash Flow Per Share (Annual)

Free Cash Flow Per Share (Annual) Chart

View Free Cash Flow Per Share (Annual) for ORMP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Free Cash Flow Per Share (Annual) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Free Cash Flow Per Share (Annual) Range, Past 5 Years

View Free Cash Flow Per Share (Annual) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Per Share (Annual) Benchmarks

View Free Cash Flow Per Share (Annual) Benchmarks
Start Trial
Lifeward Ltd. Upgrade
Bristol Myers Squibb Co. Upgrade
Nektar Therapeutics Upgrade
Innoviva, Inc. Upgrade
Theravance Biopharma, Inc. Upgrade